Diagnosis of inherited bleeding disorders in the genomic era
Summary Inherited bleeding disorders affect between 1 in 1000 individuals for the most common disorder, von Willebrand Disease, to only 8 reported cases worldwide of alpha‐2‐antiplasmin deficiency. Those with an identifiable abnormality can be divided into disorders of coagulation factors (87%), pla...
Saved in:
Published in | British journal of haematology Vol. 179; no. 3; pp. 363 - 376 |
---|---|
Main Authors | , , |
Format | Journal Article |
Language | English |
Published |
England
Blackwell Publishing Ltd
01.11.2017
|
Subjects | |
Online Access | Get full text |
ISSN | 0007-1048 1365-2141 1365-2141 |
DOI | 10.1111/bjh.14796 |
Cover
Abstract | Summary
Inherited bleeding disorders affect between 1 in 1000 individuals for the most common disorder, von Willebrand Disease, to only 8 reported cases worldwide of alpha‐2‐antiplasmin deficiency. Those with an identifiable abnormality can be divided into disorders of coagulation factors (87%), platelet count and function (8%) and the fibrinolytic system (3%). Of the patients registered in the UK with a bleeding disorder, the remaining 2% are unclassifiable. In addition to bleeding symptoms, patients with an inherited bleeding disorder can manifest other abnormalities, making an accurate and complete diagnosis that reflects the underlying molecular pathology important. Although some inherited bleeding disorders can still be easily diagnosed through a combination of careful clinical assessment and laboratory assays of varying degrees of complexity, there are many where conventional approaches are inadequate. Improvements in phenotyping assays have enhanced our diagnostic armoury but genotyping now offers the most accurate and complete diagnosis for some of these conditions. The advent of next generation sequencing technology has meant that many genes can now be analysed routinely in clinical practice. Here, we discuss the different diagnostic tools currently available for inherited bleeding disorders and suggest that genotyping should be incorporated at an early stage in the diagnostic pathway. |
---|---|
AbstractList | Summary Inherited bleeding disorders affect between 1 in 1000 individuals for the most common disorder, von Willebrand Disease, to only 8 reported cases worldwide of alpha-2-antiplasmin deficiency. Those with an identifiable abnormality can be divided into disorders of coagulation factors (87%), platelet count and function (8%) and the fibrinolytic system (3%). Of the patients registered in the UK with a bleeding disorder, the remaining 2% are unclassifiable. In addition to bleeding symptoms, patients with an inherited bleeding disorder can manifest other abnormalities, making an accurate and complete diagnosis that reflects the underlying molecular pathology important. Although some inherited bleeding disorders can still be easily diagnosed through a combination of careful clinical assessment and laboratory assays of varying degrees of complexity, there are many where conventional approaches are inadequate. Improvements in phenotyping assays have enhanced our diagnostic armoury but genotyping now offers the most accurate and complete diagnosis for some of these conditions. The advent of next generation sequencing technology has meant that many genes can now be analysed routinely in clinical practice. Here, we discuss the different diagnostic tools currently available for inherited bleeding disorders and suggest that genotyping should be incorporated at an early stage in the diagnostic pathway. Inherited bleeding disorders affect between 1 in 1000 individuals for the most common disorder, von Willebrand Disease, to only 8 reported cases worldwide of alpha-2-antiplasmin deficiency. Those with an identifiable abnormality can be divided into disorders of coagulation factors (87%), platelet count and function (8%) and the fibrinolytic system (3%). Of the patients registered in the UK with a bleeding disorder, the remaining 2% are unclassifiable. In addition to bleeding symptoms, patients with an inherited bleeding disorder can manifest other abnormalities, making an accurate and complete diagnosis that reflects the underlying molecular pathology important. Although some inherited bleeding disorders can still be easily diagnosed through a combination of careful clinical assessment and laboratory assays of varying degrees of complexity, there are many where conventional approaches are inadequate. Improvements in phenotyping assays have enhanced our diagnostic armoury but genotyping now offers the most accurate and complete diagnosis for some of these conditions. The advent of next generation sequencing technology has meant that many genes can now be analysed routinely in clinical practice. Here, we discuss the different diagnostic tools currently available for inherited bleeding disorders and suggest that genotyping should be incorporated at an early stage in the diagnostic pathway.Inherited bleeding disorders affect between 1 in 1000 individuals for the most common disorder, von Willebrand Disease, to only 8 reported cases worldwide of alpha-2-antiplasmin deficiency. Those with an identifiable abnormality can be divided into disorders of coagulation factors (87%), platelet count and function (8%) and the fibrinolytic system (3%). Of the patients registered in the UK with a bleeding disorder, the remaining 2% are unclassifiable. In addition to bleeding symptoms, patients with an inherited bleeding disorder can manifest other abnormalities, making an accurate and complete diagnosis that reflects the underlying molecular pathology important. Although some inherited bleeding disorders can still be easily diagnosed through a combination of careful clinical assessment and laboratory assays of varying degrees of complexity, there are many where conventional approaches are inadequate. Improvements in phenotyping assays have enhanced our diagnostic armoury but genotyping now offers the most accurate and complete diagnosis for some of these conditions. The advent of next generation sequencing technology has meant that many genes can now be analysed routinely in clinical practice. Here, we discuss the different diagnostic tools currently available for inherited bleeding disorders and suggest that genotyping should be incorporated at an early stage in the diagnostic pathway. Summary Inherited bleeding disorders affect between 1 in 1000 individuals for the most common disorder, von Willebrand Disease, to only 8 reported cases worldwide of alpha‐2‐antiplasmin deficiency. Those with an identifiable abnormality can be divided into disorders of coagulation factors (87%), platelet count and function (8%) and the fibrinolytic system (3%). Of the patients registered in the UK with a bleeding disorder, the remaining 2% are unclassifiable. In addition to bleeding symptoms, patients with an inherited bleeding disorder can manifest other abnormalities, making an accurate and complete diagnosis that reflects the underlying molecular pathology important. Although some inherited bleeding disorders can still be easily diagnosed through a combination of careful clinical assessment and laboratory assays of varying degrees of complexity, there are many where conventional approaches are inadequate. Improvements in phenotyping assays have enhanced our diagnostic armoury but genotyping now offers the most accurate and complete diagnosis for some of these conditions. The advent of next generation sequencing technology has meant that many genes can now be analysed routinely in clinical practice. Here, we discuss the different diagnostic tools currently available for inherited bleeding disorders and suggest that genotyping should be incorporated at an early stage in the diagnostic pathway. Inherited bleeding disorders affect between 1 in 1000 individuals for the most common disorder, von Willebrand Disease, to only 8 reported cases worldwide of alpha‐2‐antiplasmin deficiency. Those with an identifiable abnormality can be divided into disorders of coagulation factors (87%), platelet count and function (8%) and the fibrinolytic system (3%). Of the patients registered in the UK with a bleeding disorder, the remaining 2% are unclassifiable. In addition to bleeding symptoms, patients with an inherited bleeding disorder can manifest other abnormalities, making an accurate and complete diagnosis that reflects the underlying molecular pathology important. Although some inherited bleeding disorders can still be easily diagnosed through a combination of careful clinical assessment and laboratory assays of varying degrees of complexity, there are many where conventional approaches are inadequate. Improvements in phenotyping assays have enhanced our diagnostic armoury but genotyping now offers the most accurate and complete diagnosis for some of these conditions. The advent of next generation sequencing technology has meant that many genes can now be analysed routinely in clinical practice. Here, we discuss the different diagnostic tools currently available for inherited bleeding disorders and suggest that genotyping should be incorporated at an early stage in the diagnostic pathway. Inherited bleeding disorders affect between 1 in 1000 individuals for the most common disorder, von Willebrand Disease, to only 8 reported cases worldwide of alpha-2-antiplasmin deficiency. Those with an identifiable abnormality can be divided into disorders of coagulation factors (87%), platelet count and function (8%) and the fibrinolytic system (3%). Of the patients registered in the UK with a bleeding disorder, the remaining 2% are unclassifiable. In addition to bleeding symptoms, patients with an inherited bleeding disorder can manifest other abnormalities, making an accurate and complete diagnosis that reflects the underlying molecular pathology important. Although some inherited bleeding disorders can still be easily diagnosed through a combination of careful clinical assessment and laboratory assays of varying degrees of complexity, there are many where conventional approaches are inadequate. Improvements in phenotyping assays have enhanced our diagnostic armoury but genotyping now offers the most accurate and complete diagnosis for some of these conditions. The advent of next generation sequencing technology has meant that many genes can now be analysed routinely in clinical practice. Here, we discuss the different diagnostic tools currently available for inherited bleeding disorders and suggest that genotyping should be incorporated at an early stage in the diagnostic pathway. |
Author | Gomez, Keith Sivapalaratnam, Suthesh Collins, Janine |
Author_xml | – sequence: 1 givenname: Suthesh surname: Sivapalaratnam fullname: Sivapalaratnam, Suthesh organization: The Royal London Hospital – sequence: 2 givenname: Janine surname: Collins fullname: Collins, Janine organization: The Royal London Hospital – sequence: 3 givenname: Keith surname: Gomez fullname: Gomez, Keith email: k.gomez@ucl.ac.uk organization: Royal Free London NHS Foundation Trust |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/28612396$$D View this record in MEDLINE/PubMed |
BookMark | eNp10EtPGzEUBWCrooKEsugfqEbqBhZDrh8znpG64VlaIXXTri3bc504mtjUngjx7zFN2CDqjRf-zpF15uQgxICEfKZwTstZmPXqnArZtx_IjPK2qRkV9IDMAEDWFER3ROY5rwEoh4YekiPWtZTxvp2Rb9deL0PMPlfRVT6sMPkJh8qMiIMPy2rwOaYBUy6P1bTCaokhbrytMOlP5KPTY8aT_X1M_tze_L66q-9_ff9xdXFfW97wthbAgFl0HWtBciE5Mx3rmDatcEPjKDXaMdDS0l44axyYhhoU0jLWImjGj8nprvchxb9bzJPa-GxxHHXAuM2K9tBLwRroCv36hq7jNoXyu6Ia0UMnuSzqy15tzQYH9ZD8Rqcn9bpLAYsdsCnmnNAp6yc9-RimpP2oKKiX5VVZXv1bviTO3iReS9-z-_ZHP-LT_6G6_Hm3SzwDpDiPkg |
CitedBy_id | crossref_primary_10_1097_MBC_0000000000000992 crossref_primary_10_1182_hematology_2021000236 crossref_primary_10_1097_MBC_0000000000000990 crossref_primary_10_1159_000507689 crossref_primary_10_1111_bjh_15886 crossref_primary_10_1111_hae_13948 crossref_primary_10_1080_09537104_2020_1869714 crossref_primary_10_1093_labmed_lmac005 crossref_primary_10_1097_MOH_0000000000000525 crossref_primary_10_1002_jha2_664 crossref_primary_10_1515_cclm_2017_0972 crossref_primary_10_1111_scd_12713 crossref_primary_10_3390_ijms22094521 crossref_primary_10_1055_s_0044_1787661 crossref_primary_10_1097_ALN_0000000000004520 crossref_primary_10_1111_hae_13637 crossref_primary_10_1177_1076029618820164 crossref_primary_10_1111_jth_14945 crossref_primary_10_1111_jth_15479 crossref_primary_10_1016_j_paed_2017_09_001 crossref_primary_10_1111_hae_14042 crossref_primary_10_3390_ijms23147647 crossref_primary_10_1016_j_transci_2019_06_013 crossref_primary_10_1080_17474086_2019_1670638 crossref_primary_10_1002_mgg3_1075 crossref_primary_10_7759_cureus_16964 crossref_primary_10_1111_bjh_15833 crossref_primary_10_3390_biom14060714 crossref_primary_10_1002_rth2_12637 crossref_primary_10_1002_humu_24114 crossref_primary_10_1055_a_1726_4793 crossref_primary_10_1016_j_jtha_2023_11_011 crossref_primary_10_1111_hae_14195 crossref_primary_10_1080_09537104_2019_1663803 crossref_primary_10_1111_bjh_16165 crossref_primary_10_14302_issn_2372_6601_jhor_24_5108 crossref_primary_10_1111_bjh_17690 crossref_primary_10_1177_1076029618790696 crossref_primary_10_1111_hae_14438 crossref_primary_10_1186_s12859_019_2919_x crossref_primary_10_1111_hae_13922 crossref_primary_10_1055_a_2099_3266 crossref_primary_10_1016_j_ejmg_2021_104228 crossref_primary_10_1007_s00590_024_04073_8 crossref_primary_10_1080_17474086_2023_2211257 crossref_primary_10_3390_ijms22052758 crossref_primary_10_3390_jcm10020347 |
Cites_doi | 10.1126/scitranslmed.aad7666 10.1111/hae.13089 10.1186/s12881-014-0135-0 10.1002/ajh.23619 10.1182/blood-2015-12-688267 10.1182/blood-2015-09-671636 10.1111/jth.12276 10.1111/hae.12908 10.1111/jth.12332 10.1038/nature08494 10.1182/blood.V77.3.528.528 10.1182/blood-2014-08-532820 10.1111/j.1365-2141.2011.08793.x 10.1111/bjh.13058 10.1182/blood-2016-03-378588 10.1182/blood-2015-10-675629 10.1111/jth.12792 10.1182/blood-2008-08-173278 10.1182/blood-2008-06-162958 10.1016/j.cell.2016.10.042 10.1111/jth.13269 10.1172/JCI80347 10.5482/HAMO-15-05-0017 10.1093/nar/gkv1222 10.1097/MOH.0b013e3283497e3e 10.1111/j.1365-2516.2012.02759.x 10.1172/JCI86154 10.1111/j.1365-2141.2005.05599.x 10.1182/blood-2015-11-683102 10.1182/blood-2009-05-219808 10.1080/09537100802082256 10.1055/s-0029-1145254 10.1046/j.1365-2141.2001.02845.x 10.1055/s-0037-1613258 10.1111/j.1538-7836.2010.03975.x 10.1111/bjh.14471 10.1111/jth.12836 10.1038/ejhg.2015.226 10.1111/jth.12966 10.1038/ng.883 10.1097/MBC.0000000000000496 10.1111/j.1538-7836.2011.04569.x |
ContentType | Journal Article |
Copyright | 2017 John Wiley & Sons Ltd 2017 John Wiley & Sons Ltd. Copyright © 2017 John Wiley & Sons Ltd |
Copyright_xml | – notice: 2017 John Wiley & Sons Ltd – notice: 2017 John Wiley & Sons Ltd. – notice: Copyright © 2017 John Wiley & Sons Ltd |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7T5 H94 K9. 7X8 |
DOI | 10.1111/bjh.14796 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Immunology Abstracts AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Immunology Abstracts MEDLINE - Academic |
DatabaseTitleList | AIDS and Cancer Research Abstracts MEDLINE - Academic CrossRef MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1365-2141 |
EndPage | 376 |
ExternalDocumentID | 28612396 10_1111_bjh_14796 BJH14796 |
Genre | reviewArticle Research Support, Non-U.S. Gov't Journal Article Review |
GrantInformation_xml | – fundername: British Heart Foundation – fundername: Medical Research Council grantid: MR/P02002X/1 |
GroupedDBID | --- .3N .55 .GA .GJ .Y3 05W 0R~ 10A 1KJ 1OB 1OC 23N 24P 31~ 33P 36B 3O- 3SF 4.4 50Y 50Z 51W 51X 52M 52N 52O 52P 52R 52S 52T 52U 52V 52W 52X 53G 5GY 5HH 5LA 5RE 5VS 66C 6J9 6P2 702 7PT 8-0 8-1 8-3 8-4 8-5 8F7 8UM 930 A01 A03 AAESR AAEVG AAHHS AAHQN AAIPD AAKAS AAMNL AANHP AANLZ AAONW AASGY AAXRX AAYCA AAYEP AAZKR ABCQN ABCUV ABEML ABJNI ABLJU ABOCM ABPVW ABQWH ABXGK ACAHQ ACBWZ ACCFJ ACCZN ACFBH ACGFO ACGFS ACGOF ACMXC ACPOU ACPRK ACRPL ACSCC ACXBN ACXQS ACYXJ ADBBV ADBTR ADEOM ADIZJ ADKYN ADMGS ADNMO ADOZA ADXAS ADZCM ADZMN ADZOD AEEZP AEGXH AEIGN AEIMD AENEX AEQDE AEUQT AEUYR AFBPY AFEBI AFFNX AFFPM AFGKR AFPWT AFRAH AFWVQ AFZJQ AHBTC AHEFC AI. AIACR AIAGR AITYG AIURR AIWBW AJBDE ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN ALVPJ AMBMR AMYDB ASPBG ATUGU AVWKF AZBYB AZFZN AZVAB BAFTC BDRZF BFHJK BHBCM BMXJE BROTX BRXPI BY8 C45 CAG COF CS3 D-6 D-7 D-E D-F DCZOG DPXWK DR2 DRFUL DRMAN DRSTM DU5 EBS EGARE EJD EMOBN ESX EX3 F00 F01 F04 F5P FEDTE FUBAC FZ0 G-S G.N GODZA H.X HF~ HGLYW HVGLF HZI HZ~ IH2 IHE IX1 J0M J5H K48 KBYEO L7B LATKE LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LW6 LYRES MEWTI MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM N04 N05 N4W N9A NF~ O66 O9- OIG OK1 OVD P2P P2W P2X P2Z P4B P4D PALCI Q.N Q11 QB0 R.K RIWAO RJQFR ROL RX1 SAMSI SUPJJ TEORI UB1 V8K V9Y VH1 W8V W99 WBKPD WHWMO WIH WIJ WIK WIN WOHZO WOW WQJ WRC WUP WVDHM WXI WXSBR X7M XG1 YFH YOC YUY ZGI ZXP ZZTAW ~IA ~WT AAYXX AEYWJ AGHNM AGQPQ AGYGG CITATION AAMMB AEFGJ AGXDD AIDQK AIDYY CGR CUY CVF ECM EIF NPM 7T5 H94 K9. 7X8 |
ID | FETCH-LOGICAL-c3536-40202cef8260734732b8282ab64fd5f11baf20a7c194fcbf0b51be47c226e0a23 |
IEDL.DBID | DR2 |
ISSN | 0007-1048 1365-2141 |
IngestDate | Thu Jul 10 17:47:14 EDT 2025 Fri Jul 25 10:07:30 EDT 2025 Mon Jul 21 05:50:36 EDT 2025 Thu Apr 24 23:09:36 EDT 2025 Tue Jul 01 02:05:59 EDT 2025 Wed Jan 22 17:05:19 EST 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 3 |
Keywords | bleeding disorders diagnostic haematology genetics platelet disorders |
Language | English |
License | 2017 John Wiley & Sons Ltd. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c3536-40202cef8260734732b8282ab64fd5f11baf20a7c194fcbf0b51be47c226e0a23 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 ObjectType-Review-3 content type line 23 |
PMID | 28612396 |
PQID | 1954908737 |
PQPubID | 36395 |
PageCount | 14 |
ParticipantIDs | proquest_miscellaneous_1909742508 proquest_journals_1954908737 pubmed_primary_28612396 crossref_citationtrail_10_1111_bjh_14796 crossref_primary_10_1111_bjh_14796 wiley_primary_10_1111_bjh_14796_BJH14796 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | November 2017 2017-11-00 20171101 |
PublicationDateYYYYMMDD | 2017-11-01 |
PublicationDate_xml | – month: 11 year: 2017 text: November 2017 |
PublicationDecade | 2010 |
PublicationPlace | England |
PublicationPlace_xml | – name: England – name: Oxford |
PublicationTitle | British journal of haematology |
PublicationTitleAlternate | Br J Haematol |
PublicationYear | 2017 |
Publisher | Blackwell Publishing Ltd |
Publisher_xml | – name: Blackwell Publishing Ltd |
References | 2015; 13 2005; 130 1991; 77 2015; 125 2008; 19 2016; 167 2008; 34 2009; 113 2016; 128 2012; 18 2016; 127 2017; 176 2016a; 25 2011; 18 2016; 36 2012; 10 2011; 8 2009; 114 2014; 89 2016; 14 2011; 155 2013; 11 2016b; 22 2010; 115 2002; 88 2014; 15 2011; 43 2009; 461 2016; 27 2012; 22 2016; 8 2001; 114 2016; 24 2017; 127 2014; 167 2016; 22 2016; 44 e_1_2_13_25_1 e_1_2_13_24_1 e_1_2_13_27_1 e_1_2_13_26_1 e_1_2_13_21_1 e_1_2_13_44_1 e_1_2_13_20_1 e_1_2_13_45_1 e_1_2_13_23_1 Nurden A. (e_1_2_13_31_1) 2012; 22 e_1_2_13_42_1 e_1_2_13_22_1 e_1_2_13_43_1 Bastida J.M. (e_1_2_13_7_1) 2016; 25 e_1_2_13_9_1 e_1_2_13_40_1 e_1_2_13_8_1 e_1_2_13_41_1 e_1_2_13_6_1 e_1_2_13_17_1 e_1_2_13_18_1 e_1_2_13_39_1 e_1_2_13_19_1 e_1_2_13_13_1 e_1_2_13_36_1 e_1_2_13_14_1 e_1_2_13_35_1 e_1_2_13_15_1 e_1_2_13_38_1 e_1_2_13_16_1 e_1_2_13_37_1 e_1_2_13_32_1 e_1_2_13_10_1 e_1_2_13_11_1 e_1_2_13_34_1 e_1_2_13_12_1 e_1_2_13_33_1 e_1_2_13_30_1 e_1_2_13_5_1 e_1_2_13_4_1 e_1_2_13_3_1 e_1_2_13_2_1 e_1_2_13_29_1 e_1_2_13_28_1 |
References_xml | – volume: 167 start-page: 304 year: 2014 end-page: 326 article-title: Guideline for the diagnosis and management of the rare coagulation disorders publication-title: British Journal of Haematology – volume: 11 start-page: 1663 year: 2013 end-page: 1668 article-title: Utility of the ISTH bleeding assessment tool in predicting platelet defects in participants with suspected inherited platelet function disorders publication-title: Journal of Thrombosis and Haemostasis – volume: 8 start-page: 328ra30 year: 2016 article-title: A dominant gain‐of‐function mutation in universal tyrosine kinase SRC causes thrombocytopenia, myelofibrosis, bleeding, and bone pathologies publication-title: Science Translational Medicine – volume: 128 start-page: 1282 year: 2016 end-page: 1289 article-title: Novel mutations in RASGRP2, which encodes CalDAG‐GEFI, abrogate Rap1 activation, causing platelet dysfunction publication-title: Blood – volume: 43 start-page: 732 year: 2011 end-page: 734 article-title: NBEAL2 is mutated in gray platelet syndrome and is required for biogenesis of platelet α‐granules publication-title: Nature Genetics – volume: 10 start-page: 306 year: 2012 end-page: 309 article-title: Rapid genetic diagnosis of heritable platelet function disorders with next‐generation sequencing: proof‐of‐principle with Hermansky‐Pudlak syndrome publication-title: Journal of Thrombosis and Haemostasis – volume: 19 start-page: 440 year: 2008 end-page: 446 article-title: Testing agonist‐induced platelet aggregation by the Impact‐R [Cone and plate(let) analyzer (CPA)] publication-title: Platelets – volume: 125 start-page: 3600 year: 2015 end-page: 3605 article-title: SLFN14 mutations underlie thrombocytopenia with excessive bleeding and platelet secretion defects publication-title: The Journal of Clinical Investigation – volume: 114 start-page: 1091 year: 2009 end-page: 1099 article-title: A novel deletion mutation is recurrent in von Willebrand disease types 1 and 3 publication-title: Blood – volume: 115 start-page: 1267 year: 2010 end-page: 1276 article-title: The mouse mutation ‘thrombocytopenia and cardiomyopathy’ (trac) disrupts Abcg5: a spontaneous single gene model for human hereditary phytosterolemia/sitosterolemia publication-title: Blood – volume: 125 start-page: 2052 year: 2015 end-page: 2062 article-title: Rare bleeding disorders : diagnosis and treatment publication-title: Blood – volume: 77 start-page: 528 year: 1991 end-page: 532 article-title: A lifelong bleeding disorder associated with a deficiency of plasminogen activator inhibitor type 1 publication-title: Blood – volume: 15 start-page: 135 year: 2014 article-title: Recessive thrombocytopenia likely due to a homozygous pathogenic variant in the FYB gene: case report publication-title: BMC Medical Genetics – volume: 8 start-page: 2063 year: 2011 end-page: 2065 article-title: Bleeding assesment tool: a standardized questionnaire and a proposal for a new bleeding score for inherited bleeding disorders publication-title: Journal of Thrombosis and Haemostasis – volume: 127 start-page: 2814 year: 2016 end-page: 2823 article-title: Inherited platelet disorders: toward DNA‐based diagnosis publication-title: Blood – volume: 89 start-page: 320 year: 2014 end-page: 324 article-title: Specific macrothrombocytopenia/hemolytic anemia associated with sitosterolemia publication-title: American Journal of Hematology – volume: 27 start-page: 589 year: 2016 end-page: 593 article-title: The utility of International Society on Thrombosis and Haemostasis‐Bleeding Assessment Tool and other bleeding questionnaires in assessing the bleeding phenotype in two platelet function defects publication-title: Blood Coagulation & Fibrinolysis : An International Journal in Haemostasis and Thrombosis – volume: 13 start-page: 314 year: 2015 end-page: 322 article-title: Diagnosis of inherited platelet function disorders : guidance from the SSC of the ISTH publication-title: Journal of Thrombosis and Haemostasis – volume: 22 start-page: 30 year: 2012 end-page: 41 article-title: Inherited platelet disorders publication-title: Haemophilia – volume: 127 start-page: 814 year: 2017 end-page: 829 article-title: Mutations in tropomyosin 4 underlie a rare form of human macrothrombocytopenia publication-title: The Journal of Clinical Investigation – volume: 113 start-page: e1 year: 2009 end-page: e9 article-title: A HaemAtlas: characterizing gene expression in differentiated human blood cells publication-title: Blood – volume: 36 start-page: S25 year: 2016 end-page: S28 article-title: Mutational spectrum and deep intronic variants in the factor VIII gene of haemophilia A patients. Identification by next generation sequencing publication-title: Hamostaseologie – volume: 18 start-page: 366 year: 2011 end-page: 372 article-title: Novel aspects of factor XIII deficiency publication-title: Current Opinion in Hematology – volume: 127 start-page: 997 year: 2016 end-page: 1006 article-title: Mutations in AP3D1 associated with immunodeficiency and seizures define a new type of Hermansky‐Pudlak syndrome publication-title: Blood – volume: 24 start-page: 2 year: 2016 end-page: 5 article-title: Guidelines for diagnostic next‐generation sequencing publication-title: European Journal of Human Genetics – volume: 114 start-page: 4 year: 2001 end-page: 10 article-title: Congential alfa‐2‐plasmin inhibitor deficienceis: A review publication-title: British Journal of Haematology – volume: 127 start-page: 2791 year: 2016 end-page: 2804 article-title: A comprehensive high‐throughput sequencing test for the diagnosis of inherited bleeding, thrombotic and platelet disorders publication-title: Blood – volume: 22 start-page: 590 year: 2016b end-page: 597 article-title: Design and application of a 23‐gene panel by next‐generation sequencing for inherited coagulation bleeding disorders publication-title: Haemophilia – volume: 13 start-page: 1285 year: 2015 end-page: 1292 article-title: Deleterious mutation in the FYB gene is associated with congenital autosomal recessive small‐platelet thrombocytopenia publication-title: Journal of Thrombosis and Haemostasis : JTH – volume: 25 start-page: 1 year: 2016a end-page: 4 article-title: Wiskott‐Aldrich syndrome in a child presenting with macrothrombocytopenia publication-title: Platelets – volume: 14 start-page: 839 year: 2016 end-page: 849 article-title: Super‐resolution microscopy as a potential approach to diagnosis of platelet granule disorders publication-title: Journal of Thrombosis and Haemostasis – volume: 11 start-page: 1329 year: 2013 end-page: 1340 article-title: An interactive mutation database for human coagulation factor IX provides novel insights into the phenotypes and genetics of hemophilia B publication-title: Journal of Thrombosis and Haemostasis – volume: 167 start-page: 1415 year: 2016 end-page: 1429 article-title: The allelic landscape of human blood cell trait variation and links to common complex disease resource the allelic landscape of human blood cell trait variation and links to common complex disease publication-title: Cell – volume: 22 start-page: 912 year: 2016 end-page: 918 article-title: Evaluation of the utility of the ISTH‐BAT in haemophilia carriers: a multinational study publication-title: Haemophilia – volume: 44 start-page: D862 year: 2016 end-page: D868 article-title: ClinVar: public archive of interpretations of clinically relevant variants publication-title: Nucleic Acids Research – volume: 176 start-page: 705 year: 2017 end-page: 720 article-title: Dawning of the age of genomics for platelet granule disorders: improving insight, diagnosis and management publication-title: British Journal of Haematology – volume: 461 start-page: 747 year: 2009 end-page: 753 article-title: Finding the missing heritability of complex diseases publication-title: Nature – volume: 130 start-page: 297 year: 2005 end-page: 309 article-title: Stomatocytic haemolysis and macrothrombocytopenia (Mediterranean stomatocytosis/macrothrombocytopenia) is the haematological presentation of phytosterolaemia publication-title: British Journal of Haematology – volume: 34 start-page: 709 year: 2008 end-page: 733 article-title: Clinical utility of the PFA‐100 publication-title: Seminars in Thrombosis and Hemostasis – volume: 13 start-page: 643 year: 2015 end-page: 650 article-title: Use of next‐generation sequencing and candidate gene analysis to identify underlying defects in patients with inherited platelet function disorders publication-title: Journal of Thrombosis and Haemostasis – volume: 155 start-page: 30 year: 2011 end-page: 44 article-title: Guidelines for the laboratory investigation of heritable disorders of platelet function publication-title: British Journal of Haematology – volume: 127 start-page: 2903 year: 2016 end-page: 2914 article-title: A gain‐of‐function variant in DIAPH1 causes dominant macrothrombocytopenia and hearing loss publication-title: Blood – volume: 18 start-page: 630 year: 2012 end-page: 638 article-title: Retrospective evaluation of bleeding tendency and simultaneous thrombin and plasmin generation in patients with rare bleeding disorders publication-title: Haemophilia – volume: 88 start-page: 576 year: 2002 end-page: 582 article-title: The thrombogram in rare inherited coagulation disorders: its relation to clinical bleeding publication-title: Thrombosis and Haemostasis – volume: 22 start-page: 30 year: 2012 ident: e_1_2_13_31_1 article-title: Inherited platelet disorders publication-title: Haemophilia – ident: e_1_2_13_41_1 doi: 10.1126/scitranslmed.aad7666 – ident: e_1_2_13_18_1 doi: 10.1111/hae.13089 – ident: e_1_2_13_16_1 doi: 10.1186/s12881-014-0135-0 – ident: e_1_2_13_43_1 doi: 10.1002/ajh.23619 – ident: e_1_2_13_38_1 doi: 10.1182/blood-2015-12-688267 – ident: e_1_2_13_3_1 doi: 10.1182/blood-2015-09-671636 – ident: e_1_2_13_34_1 doi: 10.1111/jth.12276 – ident: e_1_2_13_8_1 doi: 10.1111/hae.12908 – ident: e_1_2_13_25_1 doi: 10.1111/jth.12332 – ident: e_1_2_13_27_1 doi: 10.1038/nature08494 – ident: e_1_2_13_10_1 doi: 10.1182/blood.V77.3.528.528 – ident: e_1_2_13_32_1 doi: 10.1182/blood-2014-08-532820 – volume: 25 start-page: 1 year: 2016 ident: e_1_2_13_7_1 article-title: Wiskott‐Aldrich syndrome in a child presenting with macrothrombocytopenia publication-title: Platelets – ident: e_1_2_13_17_1 doi: 10.1111/j.1365-2141.2011.08793.x – ident: e_1_2_13_29_1 doi: 10.1111/bjh.13058 – ident: e_1_2_13_22_1 doi: 10.1182/blood-2016-03-378588 – ident: e_1_2_13_39_1 doi: 10.1182/blood-2015-10-675629 – ident: e_1_2_13_14_1 doi: 10.1111/jth.12792 – ident: e_1_2_13_40_1 doi: 10.1182/blood-2008-08-173278 – ident: e_1_2_13_44_1 doi: 10.1182/blood-2008-06-162958 – ident: e_1_2_13_4_1 doi: 10.1016/j.cell.2016.10.042 – ident: e_1_2_13_45_1 doi: 10.1111/jth.13269 – ident: e_1_2_13_13_1 doi: 10.1172/JCI80347 – ident: e_1_2_13_5_1 doi: 10.5482/HAMO-15-05-0017 – ident: e_1_2_13_21_1 doi: 10.1093/nar/gkv1222 – ident: e_1_2_13_30_1 doi: 10.1097/MOH.0b013e3283497e3e – ident: e_1_2_13_42_1 doi: 10.1111/j.1365-2516.2012.02759.x – ident: e_1_2_13_33_1 doi: 10.1172/JCI86154 – ident: e_1_2_13_35_1 doi: 10.1111/j.1365-2141.2005.05599.x – ident: e_1_2_13_26_1 doi: 10.1182/blood-2015-11-683102 – ident: e_1_2_13_9_1 doi: 10.1182/blood-2009-05-219808 – ident: e_1_2_13_37_1 doi: 10.1080/09537100802082256 – ident: e_1_2_13_11_1 doi: 10.1055/s-0029-1145254 – ident: e_1_2_13_12_1 doi: 10.1046/j.1365-2141.2001.02845.x – ident: e_1_2_13_2_1 doi: 10.1055/s-0037-1613258 – ident: e_1_2_13_36_1 doi: 10.1111/j.1538-7836.2010.03975.x – ident: e_1_2_13_6_1 doi: 10.1111/bjh.14471 – ident: e_1_2_13_23_1 doi: 10.1111/jth.12836 – ident: e_1_2_13_28_1 doi: 10.1038/ejhg.2015.226 – ident: e_1_2_13_24_1 doi: 10.1111/jth.12966 – ident: e_1_2_13_15_1 doi: 10.1038/ng.883 – ident: e_1_2_13_20_1 doi: 10.1097/MBC.0000000000000496 – ident: e_1_2_13_19_1 doi: 10.1111/j.1538-7836.2011.04569.x |
SSID | ssj0013051 |
Score | 2.4521484 |
SecondaryResourceType | review_article |
Snippet | Summary
Inherited bleeding disorders affect between 1 in 1000 individuals for the most common disorder, von Willebrand Disease, to only 8 reported cases... Inherited bleeding disorders affect between 1 in 1000 individuals for the most common disorder, von Willebrand Disease, to only 8 reported cases worldwide of... Summary Inherited bleeding disorders affect between 1 in 1000 individuals for the most common disorder, von Willebrand Disease, to only 8 reported cases... |
SourceID | proquest pubmed crossref wiley |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 363 |
SubjectTerms | Abnormalities, Multiple - diagnosis Abnormalities, Multiple - genetics Bleeding bleeding disorders Blood Coagulation Disorders, Inherited - diagnosis Blood Coagulation Disorders, Inherited - genetics Blood Platelet Disorders - diagnosis Blood Platelet Disorders - genetics Diagnosis Diagnosis, Differential diagnostic haematology Fibrin genetics Genomics - methods Genotype Genotyping Hematology Hemophilia High-Throughput Nucleotide Sequencing - methods Humans Incidental Findings Phenotyping Physical Examination - methods platelet disorders Platelet Function Tests - methods von Willebrand Diseases - diagnosis von Willebrand Diseases - genetics |
Title | Diagnosis of inherited bleeding disorders in the genomic era |
URI | https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fbjh.14796 https://www.ncbi.nlm.nih.gov/pubmed/28612396 https://www.proquest.com/docview/1954908737 https://www.proquest.com/docview/1909742508 |
Volume | 179 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1JTyQhFH4xHoyXcVxGe1yCZg5eylBALWS8uKZjogejiQeTClAQ26Xa2N0Xf_08qEUdNTHeKuFRVAEffA8eHwB_pHFGSWojaUwZidKJSGtuIhVTXjLujAxruqdnaf9SnFwlV1Pwtz0LU-tDdAtuHhlhvPYAV3r0CuT69gZhnkkvtx3z1OvmH56zlx0EmjS35WU41Ii8URXyUTxdzrdz0TuC-ZavhgnneA6u20-t40zudiZjvWOe_1Nx_Oa__IQfDREle3XPmYcpWy3AzGmz1b4Iu4d1EN5gRIaODCp_ThDZKdH39XxHyka3c4SJBGkk8XKvDwND7JNagsvjo4uDftRctRAZnvA0eJHMWIfOBmJeZJxpdMWY0qlwZeLiWCvHqMpMLIUz2lGdxNqKzCB7s1Qx_gumq2FlV4BIndsSnSplTIK2uUol5rSUalnmIk97sN1WemEaHXJ_HcZ90fojWBtFqI0ebHWmj7X4xkdGa23LFQ3-RoXXsZM0z3jWg80uGZHjt0NUZYcTb0PRmUIKmPdguW7xrhSWe1ka__Lt0G6fF1_sn_TDw--vm67CLPPsIBxpXIPp8dPEriO3GeuN0In_AX7Z8zM |
linkProvider | Wiley-Blackwell |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwEB71IVEupVAKCy0YxKGXVI7jPCz1ArRVKLs9oK60FxTZjq1uu82ifVz66xk7D1haJMQtksdxYvuzv_HYnwE-CG21FNQEQusy4KXlgVKRDmRIo5JFVgu_pju4SPIhPx_FozU4bs_C1PoQ3YKbQ4Yfrx3A3YL0byhX11eI81Qk67Dp43OOEn1jv2IING7uy0txsOFZoyvk9vF0WVdno3sUc5Wx-inn7Al8bz-23mlyc7RcqCN994eO4__-zQ5sN1yUfKw7z1NYM9UzeDRoou27cHxS78Mbz8nUknHljgoiQSVqUk95pGykO-eYSJBJEqf4ejvWxMzkcxienV5-zoPmtoVAR3GUeEeSaWPR30DY8zRiCr0xJlXCbRnbMFTSMipTHQputbJUxaEyPNVI4AyVLNqDjWpamZdAhMpMiX6V1DpG20wmAnMaSpUoM54lPThsa73QjRS5uxFjUrQuCdZG4WujB-870x-1_sZDRvtt0xUNBOeFk7ITNEujtAfvumQEj4uIyMpMl86Goj-FLDDrwYu6ybtSWOaUadzLD33D_b344tN57h9e_bvpW9jKLwf9ov_l4utreMwcWfAnHPdhYzFbmgOkOgv1xvfon73k91E |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1JT9wwFH6iIKFeSllKp2wGceAS5DjOYsGlLKNhFaqKxKFSZDu2mJZmEDNz4dfz7CwsLRLiFsnPcWL78_uel88Am0JbLQU1gdC6CHhheaBUpAMZ0qhgkdXCz-menSe9S358FV9NwE5zFqbSh2gn3Bwy_HjtAH5b2CcgV7-vEeapSD7AFE_QTTpG9IM9LiHQuL4uL8Wxhme1rJDbxtNmfe6M_mGYzwmr9zjdGfjVfGu10eTP9niktvX9CxnHd_7MZ_hUM1Hyveo6szBhyjmYPqvX2udh96DahdcfkoEl_dIdFER6StRN5fBIUQt3DjGRII8kTu_1b18TcycX4LJ7-HO_F9R3LQQ6iqPEh5FMG4vRBoKepxFTGIsxqRJui9iGoZKWUZnqUHCrlaUqDpXhqUb6Zqhk0ReYLAel-QpEqMwUGFVJrWO0zWQiMKehVIki41nSga2m0nNdC5G7-zBu8iYgwdrIfW10YKM1va3UN_5ntNy0XF4DcJg7ITtBszRKO7DeJiN03HqILM1g7GwoRlPIAbMOLFYt3pbCMqdL416-5dvt9eLzveOef_j2dtM1mL446OanR-cnS_CROabgjzcuw-TobmxWkOeM1Krvzw_e0_YA |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Diagnosis+of+inherited+bleeding+disorders+in+the+genomic+era&rft.jtitle=British+journal+of+haematology&rft.au=Sivapalaratnam%2C+Suthesh&rft.au=Collins%2C+Janine&rft.au=Gomez%2C+Keith&rft.date=2017-11-01&rft.issn=0007-1048&rft.eissn=1365-2141&rft.volume=179&rft.issue=3&rft.spage=363&rft.epage=376&rft_id=info:doi/10.1111%2Fbjh.14796&rft.externalDBID=10.1111%252Fbjh.14796&rft.externalDocID=BJH14796 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0007-1048&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0007-1048&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0007-1048&client=summon |